Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases.

Jellinger K. The pathology of parkinsonism. In: Marsden CD, Fahn S, eds. Movement disorders Vol 2. London: Butterworths, 1987:124-65.

Jellinger K. New developments in the pathology of Parkinson's disease. In: Streifler MB, Korczyn AD, Melamed E, Youdim MBH, eds. Advances in neurology Vol 53. Parkinson's disease. Anatomy, pathology, and therapy. New York: Raven Press, 1990:1-16.

Gibb WRG, Lees AJ. The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease. J Neurol Neurosurg Psychiatry 1988;51:745-52.

Feamley JM, Lees AJ. Striatonigral degeneration: a clinicopathological study. Brain 1990;113:1823-42.

Sage JI, Miller DC, Golbe LI, Walters A, Duvoisin RC. Clinically atypical expression of pathologically typical Lewy body parkinsonism. Clin Neuropharmacol 1990:13:36-47.

Joachim CL, Morris JH, Selkoe DJ. Clinically diagnosed Alzheimer's disease: autopsy results in 150 cases. Ann Neurol 1988;24:50-6.

Lees AJ. The treatment of multiple system atrophy: striatonigral degeneration and olivopontocerebellar degeneration. In: Bannister R, ed. Autonomic failure: a textbook of clinical disorders of the autonomic nervous system, 2nd ed. Oxford: Oxford University Press, 1988:596-604.

Hoehn MM, Yahr MD. Parkinsonism: onset, progression, and mortality. Neurology 1967;17:427-42.

Oppenheimer DR. Diseases of the basal ganglia, cerebellum and motor neurons. In: Adams JH, Corsellis JAN, Duchen IW, eds. Greenfield's neuropathology, 4th ed. New York: Wiley, 1984:699-747.

Khachaturian ZS. Diagnosis of Alzheimer's disease. Arch Neurol 1985;42:1097-105.

Steele JC, Richardson JC, Olszewski J. Progressive supranuclear palsy. Arch Neurol 1964;10:333-59.

Kosaka K. Diffuse Lewy body disease in Japan. J Neurol 1990;237: 197-204.

Parkinson J. An essay on the shaking palsy. London: Sherwood, Nelly and Jones, 1817.

Forno LS, Alvord EC. The pathology of parkinsonism. In: McDowell FH, Markham CH, eds. Recent advances in Parkinson's disease. Oxford: Blackwell Scientific Publications, 1971:120-61.

Bernheimer H, Birkmayer W, Hornykiewicz 0, Jellinger K, Seitelberger F. Brain dopamine and the syndrome of parkinsonism and Huntington: clinical, morphological and neurochemical correlations. J Neurol Sci 1973;20:415-55.

Kuljis RO, Martin-Vasallo P, Peress NS. Lewy bodies in tyrosine hydroxylase-synthesizing neurons of the human cerebral cortex. Neuroscience Letters 1989;106:49-54.

Rinne JO, Rummukainen J, Paljarvi L, Sako E, Molsa P, Rinne UK. Neuronal loss in the substantia nigra in patients with Alzheimer's disease and Parkinson's disease in relation to extrapyramidal symptoms and dementia. In: Iqbal K, Wisniewski HM, Winblad B, eds. Alzheimer's disease and related disorders. New York: Alan R Liss Inc, 1989.

Morris JC, Drazner M, Fulling K, Grant EA, Goldring J. Clinical and pathological aspects of parkinsonism in Alzheimer's disease. Arch Neurol 1989;46:651-7.

Tyrrell PJ, Rossor MN. Extrapyramidal signs in dementia of the Alzheimer type. Lancet 1989;ii:920.

Daniel SD, Lees AJ. Neuropathological features of Alzheimer's disease in non-demented parkinsonian patients. J Neurol Neurosurg Psychiatry 1991;54:972-5.

Alvord EC Jr, Forno LS, Kusska JA, Kauffman RJ, Rhodes JS, Goetowski CR. The pathology of parkinsonism: a comparison of degenerations in cerebral cortex and brainstem. In: McDowell FH, Barbeau A, eds. Advances in neurology. Vol 5. New York: Raven Press, 1974:175-93.